Results 101 to 110 of about 5,948 (206)
Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3
Background Spinocerebellar ataxia type 3 (SCA3) is the most common subtype of autosomal dominantly inherited spinocerebellar ataxias (SCAs). No validated blood biomarker is available to assess either disease progression or therapeutic response ...
Quan-Fu Li +8 more
doaj +1 more source
Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado–Joseph Disease
ObjectivesSpinocerebellar ataxia type 3/Machado–Joseph disease (SCA3/MJD) is a polyglutamine disorder with no current disease-modifying treatment. Conformational changes in mutant ataxin-3 trigger different pathogenic cascades, including reactive oxygen ...
Adriano M. de Assis +39 more
doaj +1 more source
Background Spinocerebellar ataxia type 3 (SCA3) is a progressive neurodegenerative disorder caused by expansion of the polyglutamine repeat in the ataxin-3 protein.
Lodewijk J. A. Toonen +13 more
doaj +1 more source
Long non-coding RNAs (lncRNAs) play an important role in growth, development, and reproduction and undoubtedly contribute to the pathogenesis and progression of diseases.
Tianjiao Li +18 more
doaj +1 more source
n the last years progress has been made regarding the involvement of the thalamus during the course of the currently known polyglutamine diseases. Although recent studies have shown that the thalamus consistently undergoes neurodegeneration in Huntington'
Paulson, Henry +19 more
core +2 more sources
Gait features of PD and SCA3 and corresponding gait parameters computed by FLLIT.
Gait features of PD and SCA3 and corresponding gait parameters computed by FLLIT.
Kah Junn Tan (3164907) +13 more
core +1 more source
Gene-Related Cerebellar Neurodegeneration in SCA3/MJD: A Case-Controlled Imaging-Genetic Study
Background: Spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD) is one of the nine polyglutamine (polyQ) diseases and is caused by a CAG repeat expansion within the coding sequence of the ATXN3 gene.
Huirong Peng +19 more
doaj +1 more source
Pharmacological inhibition of acetylcholinesterase improves the locomotion defective phenotype of a SCA3 C. elegans model. [PDF]
Inhibition of acetylcholinesterase (AChE) is a common used treatment option for Alzheimer’s disease. However, there has been limited research on the potential use of AChE inhibitors for the treatment of Machado-Joseph disease (MJD)/Spinocerebellar Ataxia
Pohl, Franziska +5 more
core +1 more source
Disfunção executiva na ataxia espinocerebelar tipo 3 - SCA3
Dissertação (mestrado)—Universidade de Brasília, Instituto de Psicologia, Departamento de Processos Psicológicos Básicos, Programa de Pós-Graduação em Ciências do Comportamento, 2019.A pesquisa teve como objetivo avaliar as funções executivas por meio de
Freitas, Luciana de Figueiredo Pereira
core
Resumen: Introducción: Las ataxias espinocerebelosas (SCA) son un grupo de enfermedades neurodegenerativas genética, clínica y patológicamente heterogéneo, caracterizado por presentar una ataxia cerebelosa lentamente progresiva.
S. Álvarez-Paradelo +3 more
doaj +1 more source

